Beacon Therapeutics launches with £96 million ($120 million) to develop a new generation of gene therapies for retinal diseases resulting in blindness
Globe Newswire12-06-2023, 13:00
Bombardier Defense Delivers Global 6000 Aircraft to the U.S. Air Force Battlefield Airborne Communications Node (BACN) Program 23-10-2023, 17:00